Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

4 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (3)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (1)

Trial Status

Completed10
Unknown4
Active Not Recruiting3
Recruiting1
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT03291470Phase 3CompletedPrimary

Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee

NCT04255966Active Not Recruiting

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

NCT03685110Active Not RecruitingPrimary

CoreHip - Post Market Clinical Follow-Up Study

NCT05302934RecruitingPrimary

Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty

NCT03203330Phase 3Active Not RecruitingPrimary

A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee

NCT05276011Phase 2Not Yet RecruitingPrimary

A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis

NCT05742763Phase 1Withdrawn

Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis

NCT06254976Not ApplicableCompleted

Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis

NCT05427019Not ApplicableUnknownPrimary

Continuous Distal Adductor Canal Block With Periarticular Local Anesthetic Infiltration Versus Continuous Distal Adductor Canal Block Alone for Analgesia After Total Knee Arthroplasty

NCT05291130Completed

AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene

NCT02756702CompletedPrimary

All Polyethylene Tibia-VEGA Kiel

NCT03817632CompletedPrimary

Orthopilot Elite Post-Market Clinical Follow-Up

NCT03849885Phase 4UnknownPrimary

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

NCT01335243Phase 2CompletedPrimary

Efficacy and Safety Study of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Bone Marrow

NCT03442855CompletedPrimary

Non-Interventional, Multicenter Bicontact® E PMCF Study

NCT02802085CompletedPrimary

VEGA Prospective Kiel

NCT01413061Not ApplicableCompletedPrimary

Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft

NCT02687399Phase 2UnknownPrimary

Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT)

NCT01626677Phase 3CompletedPrimary

Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect

NCT02776943Phase 1Unknown

UCMSC Transplantation in the Treatment of Cartilage Damage

Showing all 20 trials

Research Network

Activity Timeline